N. TAÇYILDIZ Et Al. , "A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation," TURKISH JOURNAL OF PEDIATRICS , vol.61, no.5, pp.671-676, 2019
TAÇYILDIZ, N. Et Al. 2019. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation. TURKISH JOURNAL OF PEDIATRICS , vol.61, no.5 , 671-676.
TAÇYILDIZ, N., Tanyildiz, H. G., ÜNAL, E., DİNÇASLAN, H., Asarcikli, F., Aksoy, B. A., ... VATANSEVER, G.(2019). A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation. TURKISH JOURNAL OF PEDIATRICS , vol.61, no.5, 671-676.
TAÇYILDIZ, NURDAN Et Al. "A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation," TURKISH JOURNAL OF PEDIATRICS , vol.61, no.5, 671-676, 2019
TAÇYILDIZ, NURDAN Et Al. "A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation." TURKISH JOURNAL OF PEDIATRICS , vol.61, no.5, pp.671-676, 2019
TAÇYILDIZ, N. Et Al. (2019) . "A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation." TURKISH JOURNAL OF PEDIATRICS , vol.61, no.5, pp.671-676.
@article{article, author={NURDAN TAÇYILDIZ Et Al. }, title={A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation}, journal={TURKISH JOURNAL OF PEDIATRICS}, year=2019, pages={671-676} }